• Online Features  This Article  • Full text  • PDF  • eTable  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (22)  • Contact me when this article is cited  Related Content  • Related articles  • Similar articles in this journal  Topic Collections  • Bacterial Infections  • Infectious Diseases, Other  • Pneumonia  • Quality of Care  • Quality of Care, Other  • Statistics and Research Methods  • Prognosis/ Outcomes  • Drug Therapy  • Drug Therapy, Other  • Infectious Diseases  • Alert me on articles by topic  Social Bookmarking   What's this?

Playing by the Rules

Caitlin McCabe, BSc; Cheryl Kirchner, RN, BSN, MS; Huiling Zhang, MD, MPH, MBA; Jennifer Daley, MD, MPH; David N. Fisman, MD, MPH, FRCPC

Arch Intern Med. 2009;169(16):1525-1531.

Background  Community-acquired pneumonia (CAP) is a major cause of morbidity and mortality worldwide. Clinical practice guidelines for empirical CAP treatment, formulated jointly by the Infectious Diseases Society of America (IDSA) and American Thoracic Society (ATS), remain controversial and inconsistently applied. We evaluated the impact of guideline-concordant therapy on in-hospital survival and other outcomes using a large database including adults treated for CAP in both community and tertiary care hospitals.

Methods  We evaluated the association between in-hospital survival and guideline-concordant therapy using logistic regression models. Time until discharge from hospital and discontinuation of parenteral therapy were evaluated using survival analysis.

Results  Of 54 619 non–intensive care unit inpatients with CAP hospitalized at 113 community hospitals and tertiary care centers, 35 477 (65%) received initial guideline-concordant therapy. After adjustment for severity of illness and other confounders, guideline-concordant therapy was associated with decreased in-hospital mortality (odds ratio [OR], 0.70; 95% confidence interval [CI], 0.63-0.77), sepsis (OR, 0.83; 95% CI, 0.72-0.96), and renal failure (OR, 0.79; 95% CI, 0.67-0.94), and reduced both length of stay and duration of parenteral therapy by approximately 0.6 days (P < .001 for both comparisons). These findings were robust with alternate definitions of "concordance" and were linked to treatment with fluoroquinolone or macrolide agents.

Conclusions  Guideline-concordant therapy for CAP is associated with improved health outcomes and diminished resource use in adults. The mechanisms underlying this finding remain speculative and warrant further study, but our findings nonetheless support compliance with CAP clinical practice guidelines as a benchmark of quality of care.

Author Affiliations: Research Institute of the Hospital for Sick Children, Toronto, Ontario, Canada (Ms McCabe and Dr Fisman); Division of Clinical Quality, Tenet Healthcare, Dallas, Texas (Ms Kirchner and Dr Zhang); Partners Community Healthcare Inc and the Institute of Health Policy, Massachusetts General Hospital and Partners Healthcare, Harvard Medical School, Boston (Dr Daley); and Department of Epidemiology, Dalla Lana School of Public Health, and Department of Health Policy, Management, and Evaluation, University of Toronto, and Ontario Agency for Health Protection and Promotion, Toronto (Dr Fisman).

CiteULike    Connotea    Delicious    Digg    Facebook    Reddit    Technorati    Twitter     What's this?

RELATED ARTICLES

In This Issue of Archives of Internal Medicine
Arch Intern Med. 2009;169(16):1459.
FULL TEXT  

Guideline-Recommended Antibiotics in Community-Acquired Pneumonia: Not Perfect, but Good
Bradley A. Sharpe
Arch Intern Med. 2009;169(16):1462-1464.
EXTRACT | FULL TEXT  

Improving Outcomes in Elderly Patients With Community-Acquired Pneumonia by Adhering to National Guidelines: Community-Acquired Pneumonia Organization International Cohort Study Results
Forest W. Arnold, A. Scott LaJoie, Guy N. Brock, Paula Peyrani, Jordi Rello, Rosario Menéndez, Gustavo Lopardo, Antoni Torres, Paolo Rossi, Julio A. Ramirez, and for the Community-Acquired Pneumonia Organization (CAPO) Investigators
Arch Intern Med. 2009;169(16):1515-1524.
ABSTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Initial management of pneumonia and sepsis: factors associated with improved outcome
Menendez et al.
Eur Respir J 2012;39:156-162.
ABSTRACT | FULL TEXT  

Promoting Equity: Developing Quality Measures for Sickle Cell Disease
Tanabe and Hasnain-Wynia
American Journal of Medical Quality 2012;27:80-82.
 

Divergent Intentions to Use Antibiotic Guidelines: A Theory of Planned Behavior Survey
Cortoos et al.
Med Decis Making 2012;32:145-153.
ABSTRACT | FULL TEXT  

Empirical management of community-acquired pneumonia: impact of concurrent A/H1N1 influenza pandemic on guideline implementation
Cortoos et al.
J Antimicrob Chemother 2011;66:2864-2871.
ABSTRACT | FULL TEXT  

The Management of Community-Acquired Pneumonia in Infants and Children Older Than 3 Months of Age: Clinical Practice Guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America
Bradley et al.
Clinical Infectious Diseases 2011;53:e25-e76.
ABSTRACT | FULL TEXT  

Executive Summary: The Management of Community-Acquired Pneumonia in Infants and Children Older Than 3 Months of Age: Clinical Practice Guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America
Bradley et al.
Clinical Infectious Diseases 2011;53:617-630.
ABSTRACT | FULL TEXT  

Impact of guideline-consistent therapy on outcome of patients with healthcare-associated and community-acquired pneumonia
Grenier et al.
J Antimicrob Chemother 2011;66:1617-1624.
ABSTRACT | FULL TEXT  

An Appraisal of the Evidence Underlying Performance Measures for Community-acquired Pneumonia
Wilson and Schunemann
Am. J. Respir. Crit. Care Med. 2011;183:1454-1462.
ABSTRACT | FULL TEXT  

British Thoracic Society adult community acquired pneumonia audit 2009/10
Lim et al.
Thorax 2011;66:548-549.
ABSTRACT | FULL TEXT  

A quality improvement initiative to improve adherence to national guidelines for empiric management of community-acquired pneumonia in emergency departments
McIntosh et al.
Int J Qual Health Care 2011;23:142-150.
ABSTRACT | FULL TEXT  

Integrated Analysis of FOCUS 1 and FOCUS 2: Randomized, Doubled-Blinded, Multicenter Phase 3 Trials of the Efficacy and Safety of Ceftaroline Fosamil versus Ceftriaxone in Patients with Community-Acquired Pneumonia
File et al.
Clinical Infectious Diseases 2010;51:1395-1405.
ABSTRACT | FULL TEXT  

Quality and Strength of Evidence of the Infectious Diseases Society of America Clinical Practice Guidelines
Khan et al.
Clinical Infectious Diseases 2010;51:1147-1156.
ABSTRACT | FULL TEXT  

Skin and Soft-Tissue Infections Requiring Hospitalization at an Academic Medical Center: Opportunities for Antimicrobial Stewardship
Jenkins et al.
Clinical Infectious Diseases 2010;51:895-903.
ABSTRACT | FULL TEXT  

Evidence-Based Guidelines Can Improve Quality of Care and Reduce Costs
Rifkin and Askren-Gonzalez
Arch Intern Med 2010;170:1173-1173.
FULL TEXT  

Update in Pulmonary and Critical Care Medicine
Suffredini et al.
ANN INTERN MED 2010;152:601-608.
FULL TEXT  

Treatment algorithms in critical care: do they improve outcomes?
Nissen and Olsen
Journal of Pharmacy Practice 2010;23:61-68.
ABSTRACT | FULL TEXT  

Antibiotic Guideline Compliance and Outcomes for CAP
JWatch Emergency Med. 2009;2009:2-2.
FULL TEXT  

CAP Treatment Recommendations: Guided in the Right Direction
JWatch Infect. Diseases 2009;2009:2-2.
FULL TEXT  

Guideline-Recommended Antibiotics in Community-Acquired Pneumonia: Not Perfect, but Good
Sharpe
Arch Intern Med 2009;169:1462-1464.
FULL TEXT